U.S. PRE-MARKET MOVERS: ANR CLD CLVS EXEL IMGN JNPR KTOS MRTX

MS:US,BMO:CN,DLTR:US,JPM:US,INTC:US,DBK:GR,WFC:US,GM:US,0381073Z:US,1658186D:ID

cancer,capital-markets,science,consumer-staples,retail,infrastructure,consumer-discretionary,culture,utilities,logistics,transportation

Cancer

Capital Markets

Science

Logistics

Cleveland

Bonds

Denver

Startups

Singapore

Education

Cities

Clean Energy

Finance

Energy

Europe

Utilities

Healthcare

ESG Concerns

Infrastructure

Culture

Australia

Canada

Climate Change

Consumer Staples

Futures Markets

Currency

United States

Commodity Futures

Germany

United Kingdom

Markets

Great Britain

Retail

Industrials

Asia

Hong Kong

Americas

Fixed Income

Materials

Japan

Consumer Discretionary

Technology

Equity movers in early trading, with shrs traded pre-mkt: Advancers: ONTY +29.5% (1558.1k); ONT-380 Data Backs Plans to Initiate Phase 2 Trial OMG +27.9% (30k); To Be Bought by Apollo for $34-Shr, Premium 28% IMGN +19.4% (57.2k); Ovarian Cancer Drug Has 53% Response Rate in Study VBLT +10.7% (268.2k); Positive Ovarian Cancer Data EXEL +12.1% (119.3k); Positive Melanoma Data at ASCO ANR +10.6% (114.7k); Assumed Neutral at Goldman TGTX +8% (11.1k); Presented at ASCO SYN +7.9% (37.1k); New Outperfo

Bloomberg subscribers can save articles and view them from any device.

Upgrade to an unlimited subscription to save articles and view them from anywhere.

Bloomberg subscribers can send up to {count} articles a month to anyone to read for free, including non-subscribers.

Upgrade your subscription to send up to {count} articles a month to anyone to read for free, including non-subscribers.

Copy article link

Hello,<p>A Bloomberg.com subscriber thought you might want to read this story. To read it, all you need to do is click on the link – no subscription necessary. (Please note the link will only be valid for {days} days.)

Email article link

Please try again. If the problem persists, please contact customer support.

Something went wrong

We've doubled your gift articles this month. Share up to {count} articles with friends, family or colleagues.

As a subscriber, you can gift up to {count} articles this month. The recipient can read the full article for free – no subscription necessary.

As a subscriber, you can gift up to {count} articles each month. The recipient can read the full article for free – no subscription necessary.